STOCK TITAN

PLEXUS (PLXS) SEC Filings, Feb 5, 2026

PLXS NASDAQ

Plexus Corp.'s SEC filings document operating results, financial condition, governance matters and material corporate events for its complex product design, manufacturing and services business. Recent 8-K reports furnish quarterly and fiscal-year earnings releases and related financial information for the company's product lifecycle operations across regulated end markets.

The filings also record shareholder meeting results, including director elections, advisory executive compensation votes and auditor ratification, as well as officer transition and compensation-arrangement disclosures. These records describe formal governance actions, executive roles and recurring public-company reporting obligations for PLXS.

Form 10-Q
Rhea-AI Summary

Plexus Corp. reported fiscal Q1 2026 net sales of $1.07 billion, up about 10% from $976.1 million a year earlier, driven mainly by stronger demand in the AMER region and the Healthcare/Life Sciences sector.

Net income rose to $41.2 million from $37.3 million, with diluted EPS increasing to $1.51 from $1.34. Gross margin slipped to 9.9% from 10.3% as higher fixed costs offset some of the sales growth, while operating margin improved to 5.1% from 4.8% helped by lower restructuring charges.

Free cash flow was negative $50.6 million as the company invested in inventory to support program ramps and raised capital spending. Plexus ended the quarter with $249.4 million in cash and cash equivalents and $158.0 million in debt, finance lease and other financing obligations, and repurchased 152,987 shares for $22.4 million under its 2026 buyback program.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.56%
Tags
quarterly report
-
Rhea-AI Summary

Plexus Corp. director Jennifer Wuamett reported the vesting of restricted stock units into common shares. On February 3, 2026, 1,370 restricted stock units granted under the Plexus Corp. 2024 Omnibus Incentive Plan vested and settled into 1,370 shares of common stock. Following this transaction, she directly owns 3,349 shares of Plexus common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.56%
Tags
insider
-
Rhea-AI Summary

Plexus Corp director Michael V. Schrock reported the vesting of equity awards that delivered 1,370 shares of common stock. The shares came from Restricted Stock Units granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which vested and settled on February 3, 2026.

Following this transaction, Schrock directly held 44,329 shares of Plexus common stock. The RSUs were exercised at an effective price of $0.00 per unit, consistent with stock-based compensation rather than an open-market purchase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.56%
Tags
insider
Rhea-AI Summary

Plexus Corp director Paul A. Rooke reported the vesting of restricted stock units that converted into common shares. On February 3, 2026, 1,370 Restricted Stock Units granted under the Plexus Corp 2024 Omnibus Incentive Plan vested and settled into 1,370 shares of common stock at a stated price of $0 per share. Following this equity award settlement, Rooke directly holds 15,991 shares of Plexus common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.56%
Tags
insider
-
Rhea-AI Summary

Plexus Corp. director Karen Marie Rapp reported the vesting of equity awards and the corresponding issuance of common shares. On February 3, 2026, 1,370 Restricted Stock Units granted under the Plexus Corp. 2024 Omnibus Incentive Plan vested and settled into 1,370 shares of Plexus common stock at an exercise price of $0.00 per share. Following this conversion, she directly beneficially owned 9,035 shares of Plexus common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.56%
Tags
insider
-
Rhea-AI Summary

Plexus Corp director J. Joel Quadracci reported the vesting of equity awards under the company’s 2024 Omnibus Incentive Plan. On February 3, 2026, 1,370 Restricted Stock Units converted into an equal number of Plexus common shares at no cost. Following this settlement, Quadracci directly holds 7,478 shares of common stock, reflecting equity compensation rather than an open-market purchase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.56%
Tags
insider
Rhea-AI Summary

Plexus Corp. director Randy J. Martinez reported the vesting of equity compensation under the company’s 2024 Omnibus Incentive Plan. On February 3, 2026, 1,370 restricted stock units converted into 1,370 shares of Plexus Corp. common stock at an exercise price of $0.00 per share.

After this settlement, Martinez directly owned 6,201 shares of Plexus Corp. common stock. The restricted stock units represented a contingent right to receive one share of common stock per unit and vested and settled in full on February 3, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.56%
Tags
insider
-
Rhea-AI Summary

Plexus Corp. director Rainer Jueckstock reported an equity award vesting. On February 3, 2026, 1,370 restricted stock units granted under the Plexus Corp. 2024 Omnibus Incentive Plan vested and were settled into an equal number of Plexus common shares.

Following this automatic conversion, Jueckstock directly owned 29,740 shares of Plexus common stock. The transaction was coded as "M," reflecting the exercise or conversion of a derivative security (restricted stock units) rather than an open‑market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.56%
Tags
insider
-
Rhea-AI Summary

Plexus Corp. director Joann M. Eisenhart reported an equity award vesting under the company’s incentive plan. On February 3, 2026, 1,370 Restricted Stock Units were converted into 1,370 shares of Plexus common stock under the Plexus Corp. 2024 Omnibus Incentive Plan. Following this transaction, Eisenhart directly owned 21,705 shares of Plexus common stock. The Restricted Stock Units, each representing a right to receive one share, fully vested and settled on that date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.56%
Tags
insider
Rhea-AI Summary

Plexus Corp. shareholder Angelo M. Ninivaggi has filed a Form 144 notice to sell 4,303 shares of common stock through Morgan Stanley Smith Barney on NASDAQ around February 5, 2026, with an indicated aggregate market value of $873,767.18. The shares to be sold were acquired from the issuer as 2,683 restricted stock shares on January 31, 2025 and 1,620 performance shares on November 13, 2024, both noted as not requiring separate cash payment. The filing also reports prior sales over the past three months, including 1,347 shares sold on November 26, 2025 for gross proceeds of $195,222.06 and 2,500 shares sold on November 10, 2025 for $363,192.50.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.56%
Tags
other

FAQ

How many PLEXUS (PLXS) SEC filings are available on StockTitan?

StockTitan tracks 153 SEC filings for PLEXUS (PLXS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for PLEXUS (PLXS)?

The most recent SEC filing for PLEXUS (PLXS) was filed on November 19, 2026.